We use cookies on our website. Carry on browsing if you’re happy with this or find out more
Potent antibody drug combinations identified
Read article
Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated diseases a...
Read article
Landmark UK Supreme Court decision invalidates Regeneron Patent claims
Read article